Evidence-based treatment for opioid disorders

A 23-year national study of methadone dose levels

Thomas D'Aunno, Harold A. Pollack, Jemima A. Frimpong, David Wuchiett

Research output: Contribution to journalArticle

Abstract

Effective treatment for patients with opioid use problems is as critical as ever given the upsurge in heroin and prescription opioid abuse. Yet, results from prior studies show that the majority of methadone maintenance treatment (MMT) programs in the US have not provided dose levels that meet evidence-based standards. Thus, this paper examines the extent to which US MMT programs have made changes in the past 23. years to provide adequate methadone doses; we also identify factors associated with variation in program performance. Program directors and clinical supervisors of nationally-representative methadone treatment programs were surveyed in 1988 (n = 172), 1990 (n = 140), 1995 (n = 116), 2000 (n = 150), 2005 (n = 146), and 2011 (n = 140). Results show that the proportion of patients who received doses below 60. mg/day-the minimum recommended-declined from 79.5 to 22.8% in a 23-year span. Results from random effects models show that programs that serve a higher proportion of African-American or Hispanic patients were more likely to report low-dose care. Programs with Joint Commission accreditation were more likely to provide higher doses, as were a program that serves a higher proportion of unemployed and older patients. Efforts to improve methadone treatment practices have made substantial progress, but 23% of patients across the nation are still receiving doses that are too low to be effective.

Original languageEnglish (US)
Pages (from-to)245-250
Number of pages6
JournalJournal of Substance Abuse Treatment
Volume47
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Methadone
Opioid Analgesics
Therapeutics
Accreditation
Heroin
Hispanic Americans
African Americans
Prescriptions
Joints

Keywords

  • Dose levels
  • Methadone
  • Opioid disorders
  • Organizational correlates

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Phychiatric Mental Health
  • Medicine (miscellaneous)

Cite this

Evidence-based treatment for opioid disorders : A 23-year national study of methadone dose levels. / D'Aunno, Thomas; Pollack, Harold A.; Frimpong, Jemima A.; Wuchiett, David.

In: Journal of Substance Abuse Treatment, Vol. 47, No. 4, 2014, p. 245-250.

Research output: Contribution to journalArticle

D'Aunno, Thomas ; Pollack, Harold A. ; Frimpong, Jemima A. ; Wuchiett, David. / Evidence-based treatment for opioid disorders : A 23-year national study of methadone dose levels. In: Journal of Substance Abuse Treatment. 2014 ; Vol. 47, No. 4. pp. 245-250.
@article{de87a88d9914429f843adb777fe3f293,
title = "Evidence-based treatment for opioid disorders: A 23-year national study of methadone dose levels",
abstract = "Effective treatment for patients with opioid use problems is as critical as ever given the upsurge in heroin and prescription opioid abuse. Yet, results from prior studies show that the majority of methadone maintenance treatment (MMT) programs in the US have not provided dose levels that meet evidence-based standards. Thus, this paper examines the extent to which US MMT programs have made changes in the past 23. years to provide adequate methadone doses; we also identify factors associated with variation in program performance. Program directors and clinical supervisors of nationally-representative methadone treatment programs were surveyed in 1988 (n = 172), 1990 (n = 140), 1995 (n = 116), 2000 (n = 150), 2005 (n = 146), and 2011 (n = 140). Results show that the proportion of patients who received doses below 60. mg/day-the minimum recommended-declined from 79.5 to 22.8{\%} in a 23-year span. Results from random effects models show that programs that serve a higher proportion of African-American or Hispanic patients were more likely to report low-dose care. Programs with Joint Commission accreditation were more likely to provide higher doses, as were a program that serves a higher proportion of unemployed and older patients. Efforts to improve methadone treatment practices have made substantial progress, but 23{\%} of patients across the nation are still receiving doses that are too low to be effective.",
keywords = "Dose levels, Methadone, Opioid disorders, Organizational correlates",
author = "Thomas D'Aunno and Pollack, {Harold A.} and Frimpong, {Jemima A.} and David Wuchiett",
year = "2014",
doi = "10.1016/j.jsat.2014.06.001",
language = "English (US)",
volume = "47",
pages = "245--250",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Evidence-based treatment for opioid disorders

T2 - A 23-year national study of methadone dose levels

AU - D'Aunno, Thomas

AU - Pollack, Harold A.

AU - Frimpong, Jemima A.

AU - Wuchiett, David

PY - 2014

Y1 - 2014

N2 - Effective treatment for patients with opioid use problems is as critical as ever given the upsurge in heroin and prescription opioid abuse. Yet, results from prior studies show that the majority of methadone maintenance treatment (MMT) programs in the US have not provided dose levels that meet evidence-based standards. Thus, this paper examines the extent to which US MMT programs have made changes in the past 23. years to provide adequate methadone doses; we also identify factors associated with variation in program performance. Program directors and clinical supervisors of nationally-representative methadone treatment programs were surveyed in 1988 (n = 172), 1990 (n = 140), 1995 (n = 116), 2000 (n = 150), 2005 (n = 146), and 2011 (n = 140). Results show that the proportion of patients who received doses below 60. mg/day-the minimum recommended-declined from 79.5 to 22.8% in a 23-year span. Results from random effects models show that programs that serve a higher proportion of African-American or Hispanic patients were more likely to report low-dose care. Programs with Joint Commission accreditation were more likely to provide higher doses, as were a program that serves a higher proportion of unemployed and older patients. Efforts to improve methadone treatment practices have made substantial progress, but 23% of patients across the nation are still receiving doses that are too low to be effective.

AB - Effective treatment for patients with opioid use problems is as critical as ever given the upsurge in heroin and prescription opioid abuse. Yet, results from prior studies show that the majority of methadone maintenance treatment (MMT) programs in the US have not provided dose levels that meet evidence-based standards. Thus, this paper examines the extent to which US MMT programs have made changes in the past 23. years to provide adequate methadone doses; we also identify factors associated with variation in program performance. Program directors and clinical supervisors of nationally-representative methadone treatment programs were surveyed in 1988 (n = 172), 1990 (n = 140), 1995 (n = 116), 2000 (n = 150), 2005 (n = 146), and 2011 (n = 140). Results show that the proportion of patients who received doses below 60. mg/day-the minimum recommended-declined from 79.5 to 22.8% in a 23-year span. Results from random effects models show that programs that serve a higher proportion of African-American or Hispanic patients were more likely to report low-dose care. Programs with Joint Commission accreditation were more likely to provide higher doses, as were a program that serves a higher proportion of unemployed and older patients. Efforts to improve methadone treatment practices have made substantial progress, but 23% of patients across the nation are still receiving doses that are too low to be effective.

KW - Dose levels

KW - Methadone

KW - Opioid disorders

KW - Organizational correlates

UR - http://www.scopus.com/inward/record.url?scp=84906101723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906101723&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2014.06.001

DO - 10.1016/j.jsat.2014.06.001

M3 - Article

VL - 47

SP - 245

EP - 250

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 4

ER -